Cargando…
Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same?
BACKGROUND: We aimed to determine the predictors of regression to normoglycemia and progression to diabetes among subjects with pre-diabetes in a single model concurrently. METHODS: The present study included 1329 participants aged 20 to 70 years with prediabetes from the population-based cohort of...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585180/ https://www.ncbi.nlm.nih.gov/pubmed/36277718 http://dx.doi.org/10.3389/fendo.2022.1041808 |
_version_ | 1784813433254838272 |
---|---|
author | Alizadeh, Zeinab Baradaran, Hamid Reza Kohansal, Karim Hadaegh, Farzad Azizi, Fereidoun Khalili, Davood |
author_facet | Alizadeh, Zeinab Baradaran, Hamid Reza Kohansal, Karim Hadaegh, Farzad Azizi, Fereidoun Khalili, Davood |
author_sort | Alizadeh, Zeinab |
collection | PubMed |
description | BACKGROUND: We aimed to determine the predictors of regression to normoglycemia and progression to diabetes among subjects with pre-diabetes in a single model concurrently. METHODS: The present study included 1329 participants aged 20 to 70 years with prediabetes from the population-based cohort of the Tehran Lipid and Glucose Study, with a 10-year follow-up. Glycemic status at follow-up was categorized as regression to normoglycemia: fasting plasma glucose [FPG] of <5.55 and 2h-plasma glucose [PG] of <7.77 mmol/L, and not taking antidiabetic medications. Glycemic status at follow-up was categorized as progression to diabetes: FPG ≥7 or 2h-PG of ≥11.1 mmol/L, or taking antidiabetic medications. Glycemic status determined whether the patients remained in prediabetes category (isolated impaired fasting glycaemia [iIFG] [(5.55≤FPG<7 and 2h-PG<7.77 mmol/L); isolated impared glucose tolarence [iIGT] (7.77 ≤ 2h-PG<11.1 and FGP<5.55 mmol/L)]. With prediabetes as a reference, multinomial logistic regression was utilized to identify the determinants of glycemic changes. RESULTS: Approximately 40% of participants returned to normoglycemia (n = 578), and similar percentage of participants progressed to diabetes (n = 518). Based on the multivariable multinomial model, regression to normoglycemia was associated with age (relative risk ratio [RRR] = 0.97; 95% CI, 0.95-0.99), female sex (RRR = 1.72; 95% CI, 1.18-2.50), high education level of ≥12 years (RRR = 2.10; 95% CI, 1.19-3.70), and combined IFG/impaired glucose tolerance (IGT) versus IFG (RRR = 0.45; 95% CI, 0.29-0.70). The risk of progression to diabetes increased with body mass index (RRR = 1.10; 95% CI, 1.05-1.15), waist circumference (RRR = 0.97; 95% CI, 0.96-0.99), positive familial history of diabetes (RRR = 1.62; 95% CI, 1.07-2.45), and combined IFG/IGT versus IFG (RRR = 2.54; 95% CI, 1.71-3.77). CONCLUSION: A small percentage of patients with prediabetes remain in this condition, but the majority go on to develop diabetes or regress to normoglycemia. Both directions had distinct predictors. |
format | Online Article Text |
id | pubmed-9585180 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95851802022-10-22 Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same? Alizadeh, Zeinab Baradaran, Hamid Reza Kohansal, Karim Hadaegh, Farzad Azizi, Fereidoun Khalili, Davood Front Endocrinol (Lausanne) Endocrinology BACKGROUND: We aimed to determine the predictors of regression to normoglycemia and progression to diabetes among subjects with pre-diabetes in a single model concurrently. METHODS: The present study included 1329 participants aged 20 to 70 years with prediabetes from the population-based cohort of the Tehran Lipid and Glucose Study, with a 10-year follow-up. Glycemic status at follow-up was categorized as regression to normoglycemia: fasting plasma glucose [FPG] of <5.55 and 2h-plasma glucose [PG] of <7.77 mmol/L, and not taking antidiabetic medications. Glycemic status at follow-up was categorized as progression to diabetes: FPG ≥7 or 2h-PG of ≥11.1 mmol/L, or taking antidiabetic medications. Glycemic status determined whether the patients remained in prediabetes category (isolated impaired fasting glycaemia [iIFG] [(5.55≤FPG<7 and 2h-PG<7.77 mmol/L); isolated impared glucose tolarence [iIGT] (7.77 ≤ 2h-PG<11.1 and FGP<5.55 mmol/L)]. With prediabetes as a reference, multinomial logistic regression was utilized to identify the determinants of glycemic changes. RESULTS: Approximately 40% of participants returned to normoglycemia (n = 578), and similar percentage of participants progressed to diabetes (n = 518). Based on the multivariable multinomial model, regression to normoglycemia was associated with age (relative risk ratio [RRR] = 0.97; 95% CI, 0.95-0.99), female sex (RRR = 1.72; 95% CI, 1.18-2.50), high education level of ≥12 years (RRR = 2.10; 95% CI, 1.19-3.70), and combined IFG/impaired glucose tolerance (IGT) versus IFG (RRR = 0.45; 95% CI, 0.29-0.70). The risk of progression to diabetes increased with body mass index (RRR = 1.10; 95% CI, 1.05-1.15), waist circumference (RRR = 0.97; 95% CI, 0.96-0.99), positive familial history of diabetes (RRR = 1.62; 95% CI, 1.07-2.45), and combined IFG/IGT versus IFG (RRR = 2.54; 95% CI, 1.71-3.77). CONCLUSION: A small percentage of patients with prediabetes remain in this condition, but the majority go on to develop diabetes or regress to normoglycemia. Both directions had distinct predictors. Frontiers Media S.A. 2022-10-07 /pmc/articles/PMC9585180/ /pubmed/36277718 http://dx.doi.org/10.3389/fendo.2022.1041808 Text en Copyright © 2022 Alizadeh, Baradaran, Kohansal, Hadaegh, Azizi and Khalili https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Alizadeh, Zeinab Baradaran, Hamid Reza Kohansal, Karim Hadaegh, Farzad Azizi, Fereidoun Khalili, Davood Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same? |
title | Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same? |
title_full | Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same? |
title_fullStr | Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same? |
title_full_unstemmed | Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same? |
title_short | Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same? |
title_sort | are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same? |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585180/ https://www.ncbi.nlm.nih.gov/pubmed/36277718 http://dx.doi.org/10.3389/fendo.2022.1041808 |
work_keys_str_mv | AT alizadehzeinab arethedeterminantsoftheprogressiontotype2diabetesandregressiontonormoglycemiainthepopulationswithprediabetesthesame AT baradaranhamidreza arethedeterminantsoftheprogressiontotype2diabetesandregressiontonormoglycemiainthepopulationswithprediabetesthesame AT kohansalkarim arethedeterminantsoftheprogressiontotype2diabetesandregressiontonormoglycemiainthepopulationswithprediabetesthesame AT hadaeghfarzad arethedeterminantsoftheprogressiontotype2diabetesandregressiontonormoglycemiainthepopulationswithprediabetesthesame AT azizifereidoun arethedeterminantsoftheprogressiontotype2diabetesandregressiontonormoglycemiainthepopulationswithprediabetesthesame AT khalilidavood arethedeterminantsoftheprogressiontotype2diabetesandregressiontonormoglycemiainthepopulationswithprediabetesthesame |